Navigation Links
LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
Date:8/6/2009

WASHINGTON, Aug. 6 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) said today that bids are now being requested for another $11.8 million of the $20 million lung cancer research project funded through the Department of Defense's Congressionally Directed Medical Research Program (CDMRP).

(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO )

The solicitation invited researchers to compete for $10.5 million available for collaborative research at multiple institutions that will speed new developments in early detection and treatment from the laboratory to the patient.

Also available is $1.2 million to cover the salaries and other expenses under the Promising Clinician Research Award program and $650,000 for the Clinical Fellow Research Awards.

Pre-application submissions for all categories are due by November 11 and final applications by December 3, 2009.

In addition to the $11.5 million open to competitive bidding this week, last week the CDMRP announced $1.2 million were available for Concept Awards, smaller individual grants of up to $75,000 each to foster the development of bold new ideas in lung cancer research.

Laurie Fenton Ambrose, LCA President & CEO, said it was gratifying to see the program moving forward.

DOD first began funding cancer research with a $25 million Congressional earmark for breast cancer research in 1994 and established the CDMRP.

"Our goal has been to add a lung cancer research program to the CDMRP portfolio especially in view of the higher risk for lung cancer among military personnel and the mission oriented focus the DOD can bring to lung cancer research," she said.

"We are grateful for the Congressional support this has received," she said. "We have very high hopes for this program and will continue to work to secure additional funding."

For more information on the lung cancer research program go to: http://cdmrp.army.mil/funding/lcrp.htm.

Lung Cancer Alliance (www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer. Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

    Contact:
    Kay Cofrancesco
    kay@lungcanceralliance.org
    202-463-2080


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
2. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
3. AMN Healthcare Announces Second Quarter 2009 Results
4. IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
5. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
6. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
7. Feline Pine Announces National Take Your Cat to the Vet Day August 22
8. MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
9. Global Health Trax, Inc. Announces New Marketing Campaign for Oxygen Elements Max Product
10. CBI Announces the Agenda for Their Upcoming Access Federal Stimulus Incentives for Electronic Health Records Conference
11. Smart Balance Announces 2009 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Wethersfield, Conn. (PRWEB) , ... March 28, 2017 ... ... company based in Wethersfield, Conn., has relocated its corporate headquarters to a new, ... and clients. , In October 2016, Qualidigm purchased a distressed office building ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Self-Funding Success website has recently developed and published an informational resource that ... was created based on common inquiries the site’s team of third party administrator ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... which will be offered by the American Association of Integrative Medicine and available ... for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of ... opened in Marshallville in 2006, and a bagging and shipping facility has been in ... Patten Seed operations to the Middle Georgia location from their previous home in Lakeland, ...
(Date:3/28/2017)... ... 28, 2017 , ... Nurse practitioners and physician assistants are ... in the healthcare workforce, according to a survey recently released by PracticeMatch ... candidate leads to healthcare employers of physicians and advanced practice clinicians. , Only ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology ... global market trends of the Chemotherapy Induced Neutropenia for the seven ... Europe ( France , Germany ... , UK) and Japan , as well as ... the world (RoW). The Report covers the therapeutics market ...
(Date:3/28/2017)... 28, 2017  Rosen Law Firm, a global investor ... action lawsuit on behalf of purchasers of Kitov Pharmaceutical ... and/or traceable to Kitov,s initial public offering on or ... open market from November 20, 2015 through February 3, ... seeks to recover damages for Kitov investors under the ...
(Date:3/28/2017)... March 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... for the fourth quarter and year ended December 31, ... of transformational progress for Orexigen, beginning with the re-acquisition ... Commencing early March, the team at Orexigen demonstrated remarkable ... which reshaped and strengthened our Company while rewarding us ...
Breaking Medicine Technology: